Shares of Sareum Holdings plc (LON:SAR – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 29.49 ($0.39) and traded as low as GBX 25.35 ($0.33). Sareum shares last traded at GBX 26 ($0.34), with a volume of 411,218 shares.
Sareum Stock Down 1.9 %
The company has a market cap of £28.07 million, a P/E ratio of -433.33 and a beta of -1.08. The company has a fifty day moving average of GBX 30.33 and a 200 day moving average of GBX 29.49.
Sareum Company Profile
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases.
Recommended Stories
- Five stocks we like better than Sareum
- Are Penny Stocks a Good Fit for Your Portfolio?
- How Much Can You Make in Stocks in One Month?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- This Is the Top Large-Cap Stock Insiders Are Buying
- What Makes a Stock a Good Dividend Stock?
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Sareum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sareum and related companies with MarketBeat.com's FREE daily email newsletter.
